Skip to main content

Advertisement

Log in

Foot Infections in diabetic patients

  • Clinical trials report
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lipsky B, Pecoraro R, Larson S, et al.: Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990, 150:790–797.

    Article  PubMed  CAS  Google Scholar 

  2. Joseph WS, Tan JS: Infections in diabetic foot ulcerations. Curr Infect Dis Rep 2003, 5:391–397.

    PubMed  Google Scholar 

  3. Grayson M, Gibbons G, Habershaw G, et al.: Use of ampicillin/ sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994, 18:683–693.

    PubMed  CAS  Google Scholar 

  4. NNIS System: National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003, 31:481–498.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 1999, 48:707–710.

    Google Scholar 

  6. Naimi TS, LeDell KH, Como-Sabetti K, et al.: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976–2984.

    Article  PubMed  CAS  Google Scholar 

  7. Van Bambeke F, Van Laethem Y, Courvalin P, Tulkens PM:Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs 2004, 64:913–936.

    Article  PubMed  Google Scholar 

  8. Zhanel GG, Homenuik K, Nichol K, et al.: The glycylcyclines. A comparative review with the tetracyclines. Drugs 2004, 64:63–88.

    Article  PubMed  CAS  Google Scholar 

  9. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:624–626.

  10. Hiramatsu K, Hanaki H, Ino T, et al.: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997, 40:135–136.

    Article  PubMed  CAS  Google Scholar 

  11. Fridkin SK, Hageman JC, McDougal LK, et al.: Epidemiology and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001. Clin Infect Dis 2003, 36:429–439.

    Article  PubMed  Google Scholar 

  12. Liu C, Chambers HF: Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003, 47:3040–3045.

    Article  PubMed  CAS  Google Scholar 

  13. Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:565–567.

  14. Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:565–567.

  15. Chang S, Sievert DM, Hageman JC, et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003, 348:1342–1347.

    Article  PubMed  Google Scholar 

  16. Centers for Disease Control and Prevention: Vancomycinresistant Staphylococcus aureus--New York, 2004. MMWR Morb Mortal Wkly Rep 2004, 53:322–323.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, J.S. Foot Infections in diabetic patients. Curr Infect Dis Rep 6, 377–379 (2004). https://doi.org/10.1007/s11908-004-0036-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-004-0036-z

Keywords

Navigation